Objective: Cortical spreading depression (CSD) has long been implicated in migraine attacks with aura. The process by which CSD, a cortical event that occurs within the blood-brain barrier (BBB), results in nociceptor activation outside the BBB is likely mediated by multiple molecules and cells. The objective of this study was to determine whether CSD activates immune cells inside the BBB (pia), outside the BBB (dura), or in both, and if so, when. Methods: Investigating cellular events in the meninges shortly after CSD, we used in vivo two-photon imaging to identify changes in macrophages and dendritic cells (DCs) that reside in the pia, arachnoid, and dura and their anatomical relationship to TRPV1 axons. Results: We found that activated meningeal macrophages retract their processes and become circular, and that activated meningeal DCs stop migrating. We found that CSD activates pial macrophages instantaneously, pial, subarachnoid, and dural DCs 6-12 minutes later, and dural macrophages 20 minutes later. Dural macrophages and DCs can appear in close proximity to TRPV1-positive axons. Interpretation: The findings suggest that activation of pial macrophages may be more relevant to cases where aura and migraine begin simultaneously, that activation of dural macrophages may be more relevant to cases where headache begins 20 to 30 minutes after aura, and that activation of dural macrophages may be mediated by activation of migratory DCs in the subarachnoid space and dura. The anatomical relationship between TRPV1-positive meningeal nociceptors, and dural macrophages and DCs supports a role for these immune cells in the modulation of head pain.
M
igraine is a recurrent neurological disorder characterized as a unilateral, throbbing headache that affects approximately 27 million women and 10 million men in the United States. 1 In around 30% of cases, the headache is preceded by aura, a host of focal cortically mediated neurological symptoms that appear before and/or during the headache phase. [2] [3] [4] [5] Clinical and preclinical studies suggest that migraine aura is caused by cortical spreading depression (CSD), a slowly propagating wave of depolarization/ excitation followed by hyperpolarization/inhibition in cortical neurons and glia. 3, [6] [7] [8] Although it is possible that CSD may have some direct effect on sensory neurons within the central nervous system (CNS), 9, 10 specificity to migraine headache is almost certain to arise in activation of peripheral pain receptors in the meninges originating in the trigeminal or spinal ganglia. 11 Along this line, studies in animal models of migraine aura have shown that CSD activates meningeal nociceptors and central trigeminovascular neurons in two distinct ways-as soon as the CSD wave reaches the cortex underneath the dural receptive field of the recorded neuron, or at a delay of 20 to 45 minutes. 12, 13 Despite this research, little is known about the mechanisms by which aura can activate pain fibers in the meninges, given that no CSD-associated process has been identified yet whose time course approximates that of the immediate or delayed nociceptor activation.
Aiming to identify events that occur in the meninges during the 40-minute period that follows CSD, we sought to study the behavior of two populations of immune cells that reside in the pia, arachnoid and dura-macrophages and dendritic cells (DCs). The rationale for studying macrophages and DCs is that both are located at a strategic position along the blood-brain barrier (BBB) where they can monitor environmental changes in the CNS by sampling the cerebrospinal fluid (CSF) inside the barrier, while also promoting an inflammatory response outside the barrier. 14 Macrophages, which are highly numerous in the pia and in dura, [15] [16] [17] are usually the quickest to react to inflammatory stimuli and, consequently, considered a first line of defense. 18 In the absence of pathology, they play an important role in maintaining homeostasis in the environment in which they reside. 19, 20 On the other hand, DCs, which are fewer in number but can be found in the pia and dura as well, 15, 16 are antigen-presenting cells capable of transferring inflammatory reactions from inside the BBB to the outside, where they stimulate and attract T cells. 19, 21, 22 The rationale for studying events that relate to inflammation is that nonsteroidal anti-inflammatory drugs, attributed to their efficacy in attacks of mild and moderate severity, 23 are the most commonly used migraine abortive drugs, 24, 25 and that prostaglandins are involved in migraine pathophysiology. 26 Accordingly, the main rationale of the current study is that if CSD, a CNS event, activates macrophages and DCs in meningeal layers outside the BBB, the findings may help explain the process by which aura can trigger headache, especially given that these immune cells are capable of activating nociceptors in the meninges. 27 In this study, we determined the effects of CSD on the behavior of macrophages and DCs in all layers of the meninges using in vivo two-photon microscopy to take time-lapse three-dimensional image stacks through the skull of anesthetized fluorescently tagged transgenic mice. This technique allowed us to monitor macrophages and DCs nearsimultaneously in the dura, subarachnoid space (SAS), pia, and brain before, during, and after the induction of CSD.
Materials and Methods

Animals
All procedures involving animals were in compliance with the experimental protocol approved by the Institutional Animal Care and Use Committee of Beth Israel Deaconess Medical Center and Harvard Medical School and adhered to the guidelines of the Committee for Research and Ethical Issues of the International Association for the Study of Pain. Mice genotypic lines include wild-type, CX3C chemokine receptor 1/green fluorescent protein (CX3CR1-GFP), CD11C-YFP (yellow fluorescent protein), Trpv1-cre, and Ai14 (5582, 8829, 17769, and 7914 Jackson Labs, Bar Harbor, ME). Mice were all on C57BL/6J background. Equal numbers of male and female mice were used throughout the experiments, at 5 to 10 months old. Mice were kept in 12-hour light/dark cycles and were housed 2 to 5 per cage.
Anesthesia
Mice were deeply anesthetized using intraperitoneal injection of urethane (1.5 g/kg) and atropine (0.15 mg/kg). Using this method, we routinely kept mice at normal physiological levels (heart rate, 550-700; arterial O 2 saturation, 90-100%; breathing rate, 120-200; monitored with a MouseOx; Starr Life Science Corp, Oakmont, PA) throughout the length of the experiment.
Skull Thinning
A modified thin skull procedure was used for acute transcranial imaging based on those described previously. 28, 29 Briefly, the scalp was shaved and sterilized, a midline scalp incision was made, and a metal plate was affixed to the skull using cyanoacrylate. An area of 1.5mm in diameter was thinned on the right parietal skull plate one third of the distance from lambda to bregma posteriorly. We used a high-speed drill and a microsurgical blade to thin the skull to a thickness of 50 to 60 lm for the thin skull preparation. We found that this thickness still allows good resolution of superficial structures, but disturbs the dura minimally, as determined by intact dural blood vessels free from clotting or bleeding.
In Vivo Imaging
Fully anesthetized mice were imaged in an Olympus FV1000MPE-E multiphoton Imaging System using a SpectraPhysics Maitai Deepsee laser (70fs pulse width) and a PLAN 25X 1.05 NA objective. Three color channels were collected simultaneously (420-460nm blue in a PMT; 495-540 green and 575-630 red in GaAsP detectors). A wavelength of 890 was used to excite all fluorophores and produce second harmonic generation at 445nm (blue). After skull thinning, mice were placed in the microscope with head plate still attached. Time-lapse three-dimensional image stacks were taken covering a space from the skull through the meninges to the brain. Image resolution was 1,024 3 1,024 pixels wide with about 20 to 25 slices covering an area of 509 3 509 lm wide and 60 to 90 lm deep. For quantification of shape or position, images were taken every 3 minutes for macrophages or every 2 minutes for DCs.
CSD Initiation
CSD was initiated similar to previously described methods. 30 For both CSD and sham surgery mice, a small (<1mm 2 ) area was thinned on the frontal skull plate 1mm anterior from bregma and equidistant medial-laterally from the edges of the frontal plate. This area was chosen as it was far enough away from the imaging site that craniotomy did not affect imaged cells. The underlying dura was then exposed with a 31-gauge needle. For CSD initiation, a glass electrode tapered to approximately 30um at the tip was inserted through the dura to about 500 lm into the cortex for 20 seconds before removal.
Injections
Texas-Red conjugated 3kDalton dextran (TRD; Thermo Fisher Scientific, Waltham, MA) was injected into the tail vein or retroorbitally for intravenous injection (50 ll of 2mg/ml in saline). For intraparenchymal injection, 1 ll of 2mg/ml of TRD in synthetic interstitial fluid was slowly injected 700 to 1,000 lm beneath the dura through a glass micropipette (tip diameter of approximately 10 lm) attached to a micromanipulator. The dye was injected into a small craniotomy created using a 31-gauge needle on the corner of the imaging window (within 1mm of the location imaged). Lipopolysacharride (LPS; O26:B6 from Sigma-Aldrich, St. Louis, MO) at 1mg/kg (1mg/ml in saline) was administered by tail vein injection. All injections were performed under anesthesia.
Image Analysis
Images were analyzed using Fiji (www.fiji.sc), a version of ImageJ (NIH, Bethesda, MD).
Determination of Arrival of CSD Wave
As described in our recent study (Schain 2017) , 31 the time of the arrival of the CSD wave under the imaging window was determined by changes in blood vessel width that occurred 1 to 2 minutes post-CSD initiation. Time point 0 for "time post-CSD" was chosen as the time point previous to the time point with the strongest blood vessel constriction. In sham mice, an arbitrary time point 0 was set at 15 minutes for macrophages and 20 minutes for DCs to match the duration of baseline imaging in the respective CSD mice. See Results.
Quantification of Macrophage and DC Position and Shape
Image stacks containing macrophages or DCs were aligned over time based on background or blood vessel positions. Brightness of the stack was normalized over time to adjust for small brightness changes attributed to objective immersion water evaporation or photobleaching. Cell cross-sectional areas were then determined by thresholding maximum intensity projections through one to four slices. A custom Fiji macro using the wand tool was used to aid visual guidance in creating a selection for each individual cell over time. From the selection of each cell at each time point, XY-position, area, perimeter, and circularity were measured. Circularity is defined as ((4*pi*area)/ perimeter 2 ), which is a ratio of the perimeter of a perfect circle with the shape's area and the shape's actual perimeter. In this ratio, a perfect circle would have the highest possible value of 1.0, whereas less circular shapes will have lower values. DC speed was calculated as the distance traveled in the XY-plane from one time point to the next (2 minutes) and averaged over three 2-minute time periods (6 minutes).
Statistical Analysis
Multiple two-tailed paired Student t tests with Bonferroni correction were used to compare individual time points post-CSD (or similar time period in sham) to baseline for macrophage or DC circularity and DC speed. Multiple two-tailed Student t tests with Bonferroni correction were used to compare pial and dural macrophage circularity after CSD or pial and subarachnoid DC speed post-CSD.
Results
Baseline Characteristics of CX3CR1-Positive Macrophages To determine whether CSD alters the behavior of meningeal macrophages, we first studied their baseline anatomical appearance and behavior when undisturbed using in vivo two-photon microscopy. Images were taken through a thin skull of at least 50 lm thickness, which minimized incidence of ruptured or clotted dural blood vessels. The skull and dura were identified by second harmonic generation (SHG) generated naturally by their high levels of collagen. 32 Intravenous TRD was used to label the blood, which also allowed us to distinguish between the separate dural and pial vascular networks. 33 The pial vascular network helps to distinguish the pia from the brain because pial blood vessels run parallel to the pial surface, with branches that penetrate orthogonally into the brain. Using heterozygous CX3CR1-GFP knock-in mice, 34 macrophages were identified among GFP-positive cells by their shape, phagocytic properties, such as the uptake of TRD injected intravenously ( Fig  1A) or intraparenchymally (in separate experiments; Fig  1B) , and their macropinocytotic cellular membrane movements ( Fig 1C) . Of note, very few GFP-negative cells took up dye into vesicles in the brain or the dura within 1 hour (Fig 1A,B) . A small percentage of cells per mouse were excluded using this criteria (Fig 1A,D) . Dural and pial CX3CR1-positive macrophages in the meninges were easily distinguishable from brain microglia by shape. Macrophages are flat, with a few thick membrane extensions from their cell body, whereas microglia have many thin-branched processes and a small cell body (Figs 1B [arrowhead] and 2A). No CX3CR1-positive macrophages fitting this description were observed in the brain parenchyma below the level of the pia (images representative of n 5 16 mice). CX3CR1-positive macrophages were found in two distinct layers in the meninges: on the outer surface of the dura, just beneath the skull, and within the pia (Fig 2A,B ). Macrophages were defined as dural if they were in contact with the skull, above the SHG of the dura, and at the level of the dura vasculature, and as pial if they were at the level of the pial vasculature, as visible in orthogonal reconstructions (Fig 2B) . A crucial difference between dural and pial macrophages is that dural macrophages are outside the BBB and pial macrophages are inside. In a wild-type mouse injected intravenously with 3kDalton fluorescein isothiocyanate (FITC) dextran and intraparenchymally with 3kDalton TRD, only dural macrophages had taken up the intravenous FITC dextran, and only pial macrophages had taken up intraparenchymal TRD after one hour (Fig 2D; representative of n 5 3 mice).
There were approximately 113 6 4 macrophages in the dura and 81 6 8 in the pia, as well as 56 6 3 microglia cell bodies in the superficial cortex per 260klm 2 3 20 lm imaged volume (n 5 16 mice; Fig 2C) . No significant differences in macrophage numbers between male and female mice were detected (195 6 17 total male vs 180 6 9 total female; p (4.4) 5 0.50). At baseline, macrophages were dynamic, exhibiting phagocytosis and macropinocytosis (as in Fig 1B) , but not mobile (they were anchored to their location at least over 1-2 hours). Of note, intraparenchymal dye injections were only performed in the experiments above. In the experiments below, pial macrophages were identified morphologically.
Effect of CSD on Macrophages
Because CX3CR1-positive macrophages are present both at the pial surface, near the neurons that propagate cortical spreading depression, and on the dura, where most meningeal nociceptors are located, we determined the effects of CSD on both dural and pial macrophages. In the experimental group, we observed macrophage cellular behavior for 20 minutes before and 60 minutes after the arrival of a single CSD wave induced by pinprick. In the sham group, we observed macrophage behavior for 80 minutes after drilling a cranial window for the pinprick-but not using it to induce CSD. The most distinct change we observed was morphological. The occurrence of CSD caused macrophages to retract their cellular processes/pseudopodia ( Fig  3A,B) . We were able to quantify these shape changes by determining the circularity of the cells' shape in thresholded images, with more cellular process withdrawal resulting in more circular cells (Fig 3C-F) . Whereas macrophages became significantly more circular than baseline in the pia as soon as the CSD wave arrived (Fig 3B,D) , in the dura they became significantly more circular 20 minutes later (Fig 3A,C) . In the period of 3 to 24 minutes post-CSD, pial macrophages were significantly more circular than dural macrophages (Fig 3F; p < 0.0025, multiple t tests with Bonferroni correction). This increased circularity was observed for 40 minutes in the pia and 20 minutes in the dura, after which their processes began to extend again. In contrast, in sham-operated mice, no significant changes from baseline circularity in dural or pial macrophages were observed over the same amount of time. The single time point at which sham dural macrophage circularity was significantly different then baseline was considered anomalous because it was inconsistent with all other time points (Fig 3E) . In a comparison between CSD and sham groups, there was a significant interaction of group (CSD/sham) over time (baseline-40 minutes post-CSD) determined by two-way repeatedmeasures analysis of variance (ANOVA;
Critical to the interpretation of observed changes in macrophage and DC (see below) behavior in response to CSD was our ability to identify the time point at which the CSD wave reached the imaging window. As demonstrated in Figure 4 , the occurrence of CSD, characterized by the classical constriction of pial arteries, was documented in each experiment.
Baseline Characteristics of DCs
DCs were imaged as above in CD11c-YFP mice. 35 Their distribution, number, pinocytotic properties and mobility differed from those observed in the macrophages. Dendritic cells were found not only in the pia and dura, but also in the SAS (Fig 5A,B) . Dural DCs were defined as those with cell bodies touching the skull and above the dura, near the dural vasculature; SAS DCs were defined as those touching both the bottom of the dura and the top of the pia; and pia cells were those that appeared at the level of the pial vasculature, as visible in the orthogonal view (Fig 5B) . Note the clearly separate parallel dural and pial vasculature as well as penetrating blood vessels in the brain in Figure 5B . There were far fewer DCs than macrophages. In the same image volume (260klm 2 3 20 lm), we counted 4.0 6 0.6 in the dura, 6.7 6 1.0 in the SAS, and 8.6 6 1.3 in the pia (n 5 12 mice; Fig 5C) . DCs did not take up injected TRD in either the dural or pial compartments (n 5 3 mice; Fig  5D,E) . Two distinct classes of DCs were observed: One was anchored in place (61.7%) and the other was mobile (38.3%), migrating within ( Fig 5F) and possibly between ( Fig 5G) the different meningeal layers. Mobile cells were defined as those moving faster than 1.4 lm/min (1 standard deviation above the mean velocity for all cells). Most migrating cells were found in the pia and SAS, and only a few were observed in the dura (Fig 5H) . Although DCs have been reported in the brain, we did not observe ), for dural macrophages only. (C-E, *indicates p < 0.0025 multiple t tests with Bonferroni correction, comparing each time point to baseline). (F) Pial macrophages were significantly more circular compared to dural macrophages from 3 to 24 minutes post-CSD (*indicates p < 0.0025 multiple t tests with Bonferroni correction, comparing dura to pia for each time point). In sham mice, the dura and pial change in circularity was not significantly different at any time point.
any DC below the pial vasculature in the area of brain imaged.
Effect of CSD on DCs
To determine the effect of CSD on dural, SAS, and pial DCs, we obtained time-lapse two-photon images at 2-minute intervals for 20 minutes before and 40 minutes after the arrival of a single CSD wave, or for 60 minutes in sham-operated animals. The most noticeable change in response to CSD was observed in the mobile DC group. Regardless of their location in the different layers of the meninges, those who were mobile before CSD came almost to a halt after the CSD (Fig 6) . Compared to their average speed at baseline, CSD slowed the average velocity of the migrating DCs starting at 12 minutes post-CSD through at least 36 minutes (averaging speed over 6-minute intervals, calculated from three periods of 2 minutes; Fig 6C) . The speed of the migrating DCs was 2.2 6 0.1 lm/min at baseline, and CSD slowed the cells to 0.91 6 0.1 lm/min post-CSD, which was very close to the typical speed of the DCs we classified as anchored (0.77 6 0.03 lm/min). This slowing was significant starting 12 minutes post-CSD (6-minute intervals, calculated from three periods of 2 minutes), and happened simultaneously in all layers of the meninges ( Fig  6D) . In contrast, no significant slowing was observed in sham-operated mice (Fig 6C) . In a comparison of CSD and sham groups, there was a significant interaction of group (CSD/sham) and time (baseline-36 minutes) according to a two-way repeated-measures ANOVA (p 5 0.0011; F (9,378) 5 3.2). DCs also exhibited pseudopodia extensions that were likely not involved in phagoor macropino-cytosis, given that they did not take up injected dyes, but were perhaps linked to their motility, because they also withdrew these extensions and became more circular with a similar time frame to their cessation (Fig 6E; n55-7 mice, 22-32 DCs per group).
Effect of LPS on Macrophages and DCs
To help us interpret CSD's effects on meningeal macrophages and DCs, we injected CX3CR1-GFP and CD11c-YFP mice with the proinflammatory bacterial chemical, LPS, by the tail vein. LPS is known to cause inflammation inside and outside the BBB after systemic injection, 36 and here we used it as a positive control of macrophage and DC activation. Like CSD, intravenous injection of 1mg/kg of LPS increased the circularity of both pial and dural macrophages and slowed the speed of the mobile DC group. Macrophage circularity increased at around the same time (27-30 minutes) in both the pia and dura (n 5 2 mice, 75 macrophages; Fig  7A-C) , and the speed of DCs slowed 33 to 36 minutes after LPS injection (n 5 2 mice, 11 DCs; Fig 7D,E) .
Proximity to Trpv1-Positive Nociceptors
To map the anatomical relationship between meningeal macrophages, meningeal DCs, and meningeal nociceptors, we cross-bred CX3CR1-GFP mice and CD11c-YFP mice with mice expressing tdTomato under the Trpv1 promoter (Trpv1-cre 3 Ai14-tdTomato mice). These triple-transgenic mice express GFP or YFP in macrophages or DCs, respectively, and tdTomato red fluorescent protein in Trpv1-positive sensory axons in the dura. As demonstrated in Figure 8 , both macrophages and DCs can appear in close apposition to Trpv1-positive axons in the dura. Using these mice, we were not able to observe any Trpv1-positive axons in the pia (images representative of n 5 5 mice).
Discussion
Using in vivo two-photon imaging, we tracked two populations of immune cells that reside in the pia, SAS and dura before and after occurrence of CSD. We found that pial macrophages retracted their processes immediately after the CSD wave propagated through the cortical area just beneath them, whereas dural macrophages began to retract their processes nearly 20 minutes later. Existing literature supports the notion that macrophages adopt a rounded shape when activated. 37, 38 Based on this body of evidence and on our observation that exposure to LPS also caused the meningeal macrophages to retract their processes, we interpret the findings as suggesting that CSD activates pial macrophages earlier than it activates dural macrophages. We also observed a subgroup of CD11c 1 DCs in the pia, SAS, and dura that were highly mobile before CSD and then either came to a halt, or slowed down significantly after the CSD. In contrast to the immediate activation of pial macrophages and delayed activation of dural macrophages, the DC reaction to CSD was triggered almost simultaneously in all layers of the meninges, after a delay of 6 to 12 minutes. Here, again, existing evidence from the literature 39, 40 and our control LPS results suggest that mobile DCs stop migrating when they switch from the inactive to active state. Accordingly, we interpret the findings as suggesting that CSD activates DCs in the pia, SAS, and dura after activation of pial macrophages, but before activation of dural macrophages. A synthesis of these findings raises the following possibilities: (1) Activation of pial macrophages may be more relevant to cases in which aura and migraine begin simultaneously; (2) activation of dural macrophages 20 minutes post-CSD may be more relevant to cases in which the headache begins 20 to 30 minutes after the aura; (3) activation of DCs in the pia, dura, and SAS may depend on (be mediated by) the activation of pial macrophages; and (4) activation of dural macrophages may be mediated by activation of migratory DCs in the SAS and dura. And, finally, based on the anatomical proximity between dural macrophages, dural DCs, and dural nociceptors (ie, TRPV1-positive axons), and on macrophages' and DCs' known ability to produce or promote production of mediators (such as tumor necrosis factor alpha, interleukin [IL]-1b, and reactive oxygen species) that are capable of sensitizing or activating meningeal [41] [42] [43] and nonmeningeal nociceptors, 22, 44 it is reasonable to suggest that, when activated by CSD, these immune cells can prime, sensitize, or activate the meningeal nociceptors.
As described before, 16, 45 meningeal macrophages observed in our study lined blood vessels and connective tissues in the dura and pia. These constitutive resident macrophages are likely to maintain pia and dura homeostasis by continuously performing immune surveillance and clearance of lipoproteins, cellular debris, or dead cells using sophisticated phagocytic machinery. 18 Two distinct observations noted in the critical 40-minute period that followed the occurrence of CSD have led us to propose that aura can activate those resident macrophages that guard the steady state of the dura and pia, presumably in response to the arrival of certain proteins or cellular debris in the CSF excreted by neurons, but that it does not inflame the meninges to the extent observed in response to bacterial or viral invasion. 46, 47 The first observation noted for macrophages, which we interpreted as activation, 37, 38 was the dramatic pulling of their processes and adoption of a round shape (Fig 3) , behaviors typically associated with increased phagoor pinocytosis 20 and the release of pro-or antiinflammatory factors. 38 Activation of macrophages could be associated with both induction and resolution of inflammation. If one accepts the notion that the principle role of resident macrophages is to preserve tissue homeostasis, it may be logical to suggest that the activation observed in our study involves mainly macrophages that release antiinflammatory factors, presumably in response to increased levels of inflammatory factors after the CSD. 48, 49 This scenario is supported by in vitro studies showing that it is the anti-inflammatory macrophages that become more circular after exposure to LPS, 50 and the view that proinflammatory macrophages are newly recruited cells, 37 rather than classical resident cells that exist in the meninges and renew themselves throughout life. 15, 51, 52 The complexity of distinguishing between activation of pro-or anti-inflammatory macrophages is that in vivo, any given macrophage can switch its activation state (from releasing proinflammatory factors such as IL-1, IL-6, and IL-23 to releasing antiinflammatory factors such as IL-10) to the extent that it can facilitate both induction and resolution of inflammation. 53 Given the latter, it may be oversimplistic to propose that activated meningeal macrophages trigger an inflammatory cascade that eventually activates the nociceptors (see below). We interpreted the second observation, that the number of macrophages in the imaged tissues did not increase after CSD, as suggesting that the meninges themselves are not inflamed to the extent that one would observe after bacterial or viral meningitis, where the dura and pia are invaded by monocytes (including macrophages), neutrophils, and T cells. 46, 47 Synthesizing this information, we propose that the inflammatory/anti-inflammatory cascade that takes place in the meninges within the 40-minute period in which the headaches typically begin after aura/CSD is limited to upregulation of pro-and anti-inflammatory cytokines and chemokines capable of both facilitation and inhibition of the nociceptive drive, rather than the initiation of an adaptive immune response involving recruitment of cells from the blood. Previous anatomical studies suggested that pial, dural, and arachnoid DCs are located in areas that garner them access to CSF and to brain parenchyma. 54 These studies gave rise to the notion that unlike dura macrophages, DCs sample the CSF, and that their activation may be triggered by their ability to detect endogenous and exogenous CSFborne proteins such as myelin, toxins, or debris of damaged cells. 22 Although we agree with the anatomical data that
show that DCs are located in areas that give them access to the CSF, we are somewhat at odds with the view that their activation is triggered by the CSF sampling given that dextran injections into the CSF did not appear to label DCs in the pia, and likewise, dextran injections into the vascular system did not label DCs in the dura. In the current study, pial macrophages, which are located in areas that give them access to sample the CSF, and pinocytose dextran injected into the CSF or cortex were activated immediately after occurrence of CSD whereas pial and arachnoid/dura DCs were all activated 12 minutes later. These observations raise the possibility that activation of DCs is secondary to the activation of pial macrophages by the CSD, a proposal supported by previous studies showing that activated macrophages can, in turn, activate DCs. 55 Typically, activated
DCs exit the tissue where they live and enter lymph nodes, where they stimulate na€ ıve T cells. 22 In the current experiment, however, activated DCs did not seem to exit the meninges given that they became immobile (and remained in the tissue they were in at the time the CSD wave had occurred) during the 40-minute period in which dural nociceptors usually become activated by CSD (Fig 6) . We interpret their immobilization as a sign of activation, 39, 40 and in agreement with previous studies, 47, 56 suggest that a DCmediated recruitment of T cells may take place locally in the meninges, although at a much later time than the brief period we observed. In the context of migraine aura, it is tempting to suggest that the activated DCs stimulate the accumulation of T cells in the meninges, and in turn facilitate the "build-up" of inflammatory response that may last for the 24 to 72 hours that a typical migraine attack lastsa scenario we could not test in the current study. Given that CSD activates, rather than inhibits, meningeal nociceptors, it is more reasonable to assume that the activation of macrophages and DCs create conditions that facilitate rather than resolve inflammation. If one accepts the notion that the maintenance of tissue homeostasis (such as phagocytosis of cellular debris generated during normal tissue remodeling) is performed by unstimulated macrophages (ie, independent of immunecell signaling), and that activated macrophages, which are classically considered part of a cell-mediated immune response, typically secrete a high level of proinflammatory factors, one would be more inclined to adopt the view that the CSD-induced activation of pial and dural macrophages is more likely to increase inflammatory conditions in the exact environment in which meningeal nociceptors live. As explained above, we cannot rule out the possibility that some of the macrophage activation we observed included the anti-inflammatory alternativeactivated macrophages. This intriguing idea, that CSD may give rise to reduced, rather than enhanced, inflammatory conditions in the meninges, although judged less likely to play a role in the headache phase of migraine aura, deserves further attention. First, it may reflect the meninges' effort to maintain normalcy. Second, it may play an inhibitory role in the development of chemical and/or mechanical sensitivity by the nociceptors-a concept never tested before. A therapeutic approach that promotes activation of alternative-over classically activated macrophages in the meninges may be beneficial for counteracting the activation of the nociceptors by CSD.
In future studies, it may be important to determine whether activation of meningeal macrophages and DCs by CSD is affected by sleep deprivation or stress, and, even further, whether such activation can be induced independent of the aura or CSD, especially given that these migraine triggers are commonly associated with reduced immunity and increased inflammation.
